Merck & Co. Achieve Fivefold Performance Increase for Critical Research Platform
sponsored by Oracle Corporation UK Ltd
As the volume of data continues to grow, many companies are finding that legacy database platforms lack the necessary scalability, agility, and performance for today’s market. Merck & Co., a global research-driven pharmaceutical company, was experiencing such extreme growth in their database that application performance was starting to suffer.
Download this case study to uncover how Merck & Co. overcame their database dilemma by implementing an innovative platform that enabled them to:
- Reduce memory utilization by 40%
- Increase system speed by 5x
- Increase efficiency
- And more.
(THIS RESOURCE IS NO LONGER AVAILABLE.)